These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19372900)

  • 1. Antiretroviral therapy-induced lipid alterations: in-vitro, animal and human studies.
    Mallon PW
    Curr Opin HIV AIDS; 2007 Jul; 2(4):282-92. PubMed ID: 19372900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
    Martínez E; Tuset M; Milinkovic A; Miró JM; Gatell JM
    Antivir Ther; 2004 Oct; 9(5):649-63. PubMed ID: 15535403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of cardiovascular disease in HIV infection.
    Carr A
    Curr Opin HIV AIDS; 2008 May; 3(3):234-9. PubMed ID: 19372972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of HIV protease inhibitors: clinical considerations.
    Boesecke C; Cooper DA
    Curr Opin HIV AIDS; 2008 Nov; 3(6):653-9. PubMed ID: 19373038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral and statin drug-drug interactions.
    Ray GM
    Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy in coinfected patients: viral hepatitis and tuberculosis.
    Rockstroh JK; Hardy WD
    Curr Opin HIV AIDS; 2006 Sep; 1(5):442-8. PubMed ID: 19372845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of antiretroviral-induced mitochondrial dysfunction in adipocytes and adipose tissue: in-vitro, animal and human adipose tissue studies.
    Villarroya F; Domingo P; Giralt M
    Curr Opin HIV AIDS; 2007 Jul; 2(4):261-7. PubMed ID: 19372897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of HIV protease inhibitors in pregnancy.
    van der Lugt J; Colbers A; Burger D
    Curr Opin HIV AIDS; 2008 Nov; 3(6):620-6. PubMed ID: 19373033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte dysfunction in response to antiretroviral therapy: clinical, tissue and in-vitro studies.
    Caron M; Vigouroux C; Bastard JP; Capeau J
    Curr Opin HIV AIDS; 2007 Jul; 2(4):268-73. PubMed ID: 19372898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of drug interaction with antiretroviral agents.
    Pau AK
    Curr Opin HIV AIDS; 2008 May; 3(3):319-24. PubMed ID: 19372985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of early virological failure.
    Sax PE
    Curr Opin HIV AIDS; 2006 Sep; 1(5):409-16. PubMed ID: 19372840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men.
    Ware LJ; Jackson AG; Wootton SA; Burdge GC; Morlese JF; Moyle GJ; Jackson AA; Gazzard BG
    Br J Nutr; 2009 Oct; 102(7):1038-46. PubMed ID: 19480729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy and cardiovascular risk: are some medications cardioprotective?
    Eckhardt BJ; Glesby MJ
    Curr Opin HIV AIDS; 2008 May; 3(3):226-33. PubMed ID: 19372971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory issues in developing new HIV protease inhibitors: risks and benefits.
    Struble KA; Chan-Tack KM; Soon GG
    Curr Opin HIV AIDS; 2008 Nov; 3(6):676-80. PubMed ID: 19373041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A regulatory perspective on the role of drug interactions in antiretroviral drug development.
    Struble KA; Reynolds KS
    Curr Opin HIV AIDS; 2008 May; 3(3):325-9. PubMed ID: 19372986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopenia and osteoporosis in HIV: pathogenesis and treatment.
    Chew NS; Doran PP; Powderly WG
    Curr Opin HIV AIDS; 2007 Jul; 2(4):318-23. PubMed ID: 19372906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early antiretroviral therapy mortality in resource-limited settings: what can we do about it?
    Bekker LG; Egger M; Wood R
    Curr Opin HIV AIDS; 2007 Jul; 2(4):346-51. PubMed ID: 19372910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of the inhibitory quotient: is there a role in HIV protease inhibitor therapy?
    Winston A; Khoo S
    Curr Opin HIV AIDS; 2008 Nov; 3(6):608-11. PubMed ID: 19373031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of lipid-lowering therapy in HIV patients.
    Martínez E; Leyes P; Ros E
    Curr Opin HIV AIDS; 2008 May; 3(3):240-6. PubMed ID: 19372973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.